問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2019-09-01 - 2024-12-31
Condition/Disease
Advanced Solid Tumors
Test Drug
BA3021
Participate Sites4Sites
Recruiting4Sites
2019-09-15 - 2024-01-30
Moderately to Severely Active Ulcerative Colitis
Etrasimod
Participate Sites7Sites
Recruiting6Sites
Terminated1Sites
2021-08-01 - 2029-12-31
Participate Sites5Sites
Recruiting5Sites
2022-01-01 - 2025-02-28
Participate Sites2Sites
Recruiting2Sites
2021-05-01 - 2024-12-31
Not yet recruiting1Sites
2021-06-01 - 2026-02-01
Participate Sites6Sites
2021-03-01 - 2023-12-29
2021-03-01 - 2023-11-27
Recruiting7Sites
2021-04-01 - 2024-12-31
2020-05-01 - 2025-03-31
Chronic Hepatitis B Infection
RO7049389、RO7020531、Vemlidy韋立得、Viread 惠立妥、Baraclude 貝樂克
全部
